Area of research
Cancer Research · Otorhinolaryngology
Research interest
Research interests include Head and Neck Cancer Studies, MicroRNA in disease regulation, Cancer-related molecular mechanisms research, and Cancer Genomics and Diagnostics.
Activated ATF6α is a hepatic tumour driver restricting immunosurveillance
EGFR-mediated local invasiveness and response to Cetuximab in head and neck cancer
A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic cancer development
Targeting VEGF‐A in an Immunocompetent Orthotopic Mouse Model of Mesenchymal Glioblastoma Improves Antitumorigenicity and Decreases Proinflammatory Response in Normal Brain Tissue after Fractionated Radiotherapy
ChatGPT's Gastrointestinal Tumor Board Tango: A limping dance partner?
HBV-related HCC development in mice is STAT3 dependent and indicates an oncogenic effect of HBx
ChatGPT's Gastrointestinal Tumor Board Tango: A limping dance partner?
Adjuvant (chemo)radiotherapy for patients with head and neck cancer: can comorbidity risk scores predict outcome?
Metabolomic Analysis of Human Cirrhosis and Hepatocellular Carcinoma: A Pilot Study.
Metabolic pathway-based subtypes associate glycan biosynthesis and treatment response in head and neck cancer
Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12).
Sublethal necroptosis signaling promotes inflammation and liver cancer
Sublethal necroptosis signaling promotes inflammation and liver cancer.
Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling
Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling.
Systematic in vitro analysis of therapy resistance in glioblastoma cell lines by integration of clonogenic survival data with multi-level molecular data
Comparative computational analysis to distinguish mesenchymal stem cells from fibroblasts.
Systematic in vitro analysis of therapy resistance in glioblastoma cell lines by integration of clonogenic survival data with multi-level molecular data.
Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12)
A Novel Subgroup of UCHL1-Related Cancers Is Associated with Genomic Instability and Sensitivity to DNA-Damaging Treatment
A Novel Subgroup of UCHL1-Related Cancers Is Associated with Genomic Instability and Sensitivity to DNA-Damaging Treatment.
DNA-methylation and genomic copy number in primary tumors and corresponding lymph node metastases in prostate cancer from patients with low and high Gleason score
Mcl-1 deficiency in murine livers leads to nuclear polyploidisation and mitotic errors: Implications for hepatocellular carcinoma
DNA-methylation and genomic copy number in primary tumors and corresponding lymph node metastases in prostate cancer from patients with low and high Gleason score.
A transcriptomic map of EGFR-induced epithelial-to-mesenchymal transition identifies prognostic and therapeutic targets for head and neck cancer.
Replication stress triggered by nucleotide pool imbalance drives DNA damage and cGAS-STING pathway activation in NAFLD
Replication stress triggered by nucleotide pool imbalance drives DNA damage and cGAS-STING pathway activation in NAFLD.
APOBEC-mediated mutagenesis is a favorable predictor of prognosis and immunotherapy for bladder cancer patients: evidence from pan-cancer analysis and multiple databases.
Machine Learning Classifies Ferroptosis and Apoptosis Cell Death Modalities with TfR1 Immunostaining.
Therapy-Related Transcriptional Subtypes in Matched Primary and Recurrent Head and Neck Cancer.